Regulations.gov document
Bristol Myers Products Inc.; Proposal To Withdraw Approval of a New Drug Application for…
Notice · FDA-2022-N-2796 · posted Nov 23, 2022
Key facts
| Document ID | FDA-2022-N-2796-0001 |
|---|---|
| Title | Bristol Myers Products Inc.; Proposal To Withdraw Approval of a New Drug Application for Bufferin (Aspirin) Tablets; Opportunity for a Hearing |
| Document type | Notice |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-2022-N-2796 |
| Posted | Nov 23, 2022 |
| Federal Register citation | 87 FR 71652 |
| FR document number | 2022-25516 |
| Comment period opens | Nov 23, 2022 |
| Comments due | Jan 24, 2023 |
| Effective date | Nov 23, 2022 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: